Back

Renal dysfunction drives recurrence and modifies safety after atrial fibrillation ablation: a contemporary retrospective analysis of CKD stage and energy source interaction

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation, renal dysfunction, and atrial cardiomyopathy: substrate and clinical outcomes Heart Failure in Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Doctor Rakhshanda Khan

(India)

Photo
Doctor Harshawardhan Dhanraj Ramteke

Chimur (India)

6 More presentations in this session

Presentation thumbnail
Silicon carbide nanowires preserve human atrial microtissue function and show a preliminary reduction of AF duration in an aged-rat atrial tachypacing model
Associate Professor M. Miragoli (Parma, IT)
Abstract Slides Video
Presentation thumbnail
Genetic determinants of renal function across atrial fibrillation phenotypes in hypertensive patients: analysis of six polymorphisms
Assistant Professor Z. Mashkurova (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Association of atrial fibrillation and chronic kidney disease with cerebral microbleeds
Mr N. Gisler (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Pacing-induced repolarization alternans within the pulmonary veins and its association with atrial fibrillation inducibility
Doctor S. Tanabe (Gifu, JP)
Abstract Slides Video
Presentation thumbnail
Distribution and clinical utility of the kidney disease improving global outcomes chronic kidney disease risk classification in patients undergoing atrial fibrillation ablation
Doctor H. Ishiguchi (Ube, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation, renal dysfunction, and atrial cardiomyopathy: substrate and clinical outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes of atrial fibrillation ablation in patients with chronic kidney disease
30 March 2025
thumbnail
Congress Presentation
Predictors of long-term atrial fibrillation recurrence following catheter ablation: a UK multicenter study
31 August 2026
thumbnail
Congress Presentation
Predictions of adverse outcomes using different renal function estimation formulas in patients with atrial fibrillation receiving direct oral anticoagulants
30 August 2026
thumbnail
Congress Presentation
In-hospital outcomes of atrial fibrillation catheter ablation in patients with baseline anemia or thrombocytopenia: a nationwide analysis from the National Inpatient Sample (2016–2021)
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources